Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E DuPuis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
AACN Clinical Issues in Critical Care Nursing|November 1, 1991
Anticonvulsants: pharmacotherapeutic issues in the critically ill patientR E Dupuis, J Miranda-Massari
The American Journal of Medicine|January 1, 1985
Severe theophylline toxicityR L Slaughter, R E DuPuis
Therapeutic Drug Monitoring|April 27, 1999
Tobramycin pharmacokinetics in patients with cystic fibrosis preceding and following lung transplantationR E Dupuis, E S Sredzienski
The Annals of Pharmacotherapy|September 1, 1995
Approaches to the treatment of hyperlipidemia in the solid organ transplant recipientJ K Kirk, R E Dupuis
DICP : the Annals of Pharmacotherapy|May 1, 1991
Significance of the ciprofloxacin-antacid interactionM K Roush, R E Dupuis
Drug Safety|January 1, 1990
Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolitesR E Dupuis, S N Lichtman, G M Pollack
Clinical Pharmacy|November 1, 1986
Patient-location-specific alterations in aminoglycoside volume of distributionR A Pleasants, W T Sawyer, R E Dupuis, et al.
The Annals of Pharmacotherapy|April 1, 1996
Multiple delayed peak lithium concentrations following acute intoxication with an extended-release productR E Dupuis, A A Cooper, L J Rosamond, et al.
Clinical Pharmacy|May 1, 1989
Vancomycin disposition during continuous arteriovenous hemofiltrationR E Dupuis, G R Matzke, F W Maddux, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 17, 2001
Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatographyK Wiwattanawongsa, E L Heinzen, D C Kemp, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
AACN Clinical Issues in Critical Care Nursing|November 1, 1991
Anticonvulsants: pharmacotherapeutic issues in the critically ill patientR E Dupuis, J Miranda-Massari
The American Journal of Medicine|January 1, 1985
Severe theophylline toxicityR L Slaughter, R E DuPuis
Therapeutic Drug Monitoring|April 27, 1999
Tobramycin pharmacokinetics in patients with cystic fibrosis preceding and following lung transplantationR E Dupuis, E S Sredzienski
The Annals of Pharmacotherapy|September 1, 1995
Approaches to the treatment of hyperlipidemia in the solid organ transplant recipientJ K Kirk, R E Dupuis
DICP : the Annals of Pharmacotherapy|May 1, 1991
Significance of the ciprofloxacin-antacid interactionM K Roush, R E Dupuis
Drug Safety|January 1, 1990
Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolitesR E Dupuis, S N Lichtman, G M Pollack
Clinical Pharmacy|November 1, 1986
Patient-location-specific alterations in aminoglycoside volume of distributionR A Pleasants, W T Sawyer, R E Dupuis, et al.
The Annals of Pharmacotherapy|April 1, 1996
Multiple delayed peak lithium concentrations following acute intoxication with an extended-release productR E Dupuis, A A Cooper, L J Rosamond, et al.
Clinical Pharmacy|May 1, 1989
Vancomycin disposition during continuous arteriovenous hemofiltrationR E Dupuis, G R Matzke, F W Maddux, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 17, 2001
Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatographyK Wiwattanawongsa, E L Heinzen, D C Kemp, et al.
Pageof 2